drugset / Trial / NCT04740203
Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL
NaSingle-groupOpen-labelTreatment
Summary
Clinical Trial for the Safety and Efficacy of Sequential CD19 and CD22 CAR-T Therapy for Adult Patients With Newly Diagnosed Ph Chromosome Negative B-cell Acute Lymphoblastic Leukemia
Timeline
- Start
- 2021-01-31
- Primary completion
- 2024-01-31
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CAR-T cells targeting CD19 | Cell therapy | — | Intravenous |
| Subject | CD20/CD22/CD10-CART | Cell therapy | — | Intravenous |